These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Diner BM Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695 [No Abstract] [Full Text] [Related]
3. Aspirin for atrial fibrillation. Douglas M; Strelnick A J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329 [No Abstract] [Full Text] [Related]
4. [Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation]. Rodríguez D; Agustí A Med Clin (Barc); 1999 Mar; 112(11):436-7. PubMed ID: 10231778 [No Abstract] [Full Text] [Related]
5. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]. Pengo V; De Caterina R Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834 [TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
8. Balancing risk in atrial fibrillation. Ali SN; Hardman SM Practitioner; 2001 May; 245(1622):357. PubMed ID: 11373966 [No Abstract] [Full Text] [Related]
9. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk]. Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287 [TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
11. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
14. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience. Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for atrial fibrillation: underuse? Pechlaner C Am J Med; 2011 Jul; 124(7):e11; author reply e13. PubMed ID: 21683818 [No Abstract] [Full Text] [Related]
16. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
17. Anticoagulation in people with atrial fibrillation. Fang MC BMJ; 2011 Jan; 342():d530. PubMed ID: 21282259 [No Abstract] [Full Text] [Related]
18. [Prevention of thromboembolism in heart infarct, cardiomyopathy and atrial fibrillation]. Straub PW Schweiz Med Wochenschr; 1990 Mar; 120(11):365-71. PubMed ID: 2181642 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis. Garton AB; Dudzinski J; Kowey PR J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]